Acarbose belongs to a class of oral medications known as alpha-glucosidase inhibitors [1]. These drugs work by slowing down the digestion of carbohydrates in the digestive tract [2].
How do alpha-glucosidase inhibitors like acarbose affect blood sugar?
Alpha-glucosidase inhibitors target enzymes in the small intestine that are responsible for breaking down complex carbohydrates into simple sugars, such as glucose. By inhibiting these enzymes, the absorption of glucose into the bloodstream is delayed [1][2]. This leads to a more gradual rise in blood sugar levels after meals, which is particularly beneficial for individuals with type 2 diabetes [3].
What is acarbose prescribed for?
Acarbose is prescribed to improve glycemic control in adults with type 2 diabetes mellitus [3]. It is typically used in conjunction with diet and exercise, and may be used alone or in combination with other diabetes medications [4].
What are the potential side effects of acarbose?
The most common side effects associated with acarbose include gastrointestinal issues such as diarrhea, abdominal pain, and flatulence [3][4]. These side effects are generally dose-dependent and may decrease over time or with dose adjustment [3].
How does acarbose compare to other diabetes medications?
Acarbose's mechanism of action, delaying carbohydrate digestion, differs from other classes of diabetes medications like metformin (which reduces glucose production by the liver and improves insulin sensitivity) or sulfonylureas (which stimulate insulin release from the pancreas) [4]. Its primary effect is on post-meal blood sugar spikes.
When did acarbose patents expire?
Information regarding specific patent expiry dates for acarbose and its formulations can be found on specialized patent tracking websites [5]. DrugPatentWatch.com provides detailed patent information, including expiry dates, for various pharmaceutical products [5].